BPC-157 vs TB-500
BPC-157 and TB-500 are the two most sought-after healing peptides in regenerative medicine. One is derived from the gut, the other from the thymus. Both accelerate recovery, but through distinctly different mechanisms. Here is how they compare and when to use each.
BPC-157
Body Protection Compound (gut-derived)
BPC-157 is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It accelerates healing by upregulating growth factor receptors (VEGF, FGF, EGF), promoting angiogenesis, modulating nitric oxide pathways, and reducing inflammation. Its gastric stability makes it uniquely effective both orally and via injection.
Best For:
- Tendon & ligament injuries (Achilles, rotator cuff)
- Gut healing (leaky gut, IBS, ulcers)
- Joint inflammation & arthritis
- Post-surgical tissue repair
- Nerve damage & neuroprotection
- NSAID-induced GI damage repair
TB-500
Thymosin Beta-4 fragment (thymus-derived)
TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring peptide present in nearly all human and animal cells. It promotes healing by regulating actin, a cell-building protein critical for cell migration, blood vessel formation, and tissue repair. TB-500 has a systemic effect, meaning it can travel through the body to find and repair damaged tissue regardless of injection site.
Best For:
- Muscle tears & strains
- Cardiac tissue repair
- Systemic inflammation reduction
- Flexibility & range of motion improvement
- Hair regrowth (follicle stem cell activation)
- Chronic injury recovery (overuse injuries)
Head-to-Head Comparison
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Origin | Gastric juice (gut-derived) | Thymus gland (thymus-derived) |
| Full Name | Body Protection Compound-157 | Thymosin Beta-4 fragment |
| Primary Mechanism | Upregulates growth factor receptors & nitric oxide | Promotes actin regulation & cell migration |
| Best for Tendons/Ligaments | Excellent | Good |
| Best for Muscle Injuries | Good | Excellent |
| Gut Healing | Excellent (primary strength) | Minimal direct effect |
| Cardiac Tissue Repair | Moderate | Strong (studied in cardiac models) |
| Administration Routes | Subcutaneous, oral, intramuscular | Subcutaneous, intramuscular |
| Typical Dosing | 250-500 mcg 1-2x daily | 2-5 mg 2x per week |
| Cycle Length | 4-8 weeks | 4-6 weeks |
| Oral Bioavailability | Yes (stable in gastric acid) | No (must be injected) |
| Research Stage | Extensive animal studies, clinical use growing | Animal studies, clinical trials emerging |
| Anti-Inflammatory | Strong | Moderate |
| Side Effects | Minimal (mild nausea rare) | Minimal (injection site irritation) |
| Stacking Compatibility | Excellent (pairs well with TB-500) | Excellent (pairs well with BPC-157) |
The Bottom Line
Choose BPC-157 if your primary concern is tendon or ligament healing, gut repair, or localized joint inflammation. Its oral bioavailability also makes it the only peptide option for patients who prefer to avoid injections entirely. BPC-157 is especially effective for connective tissue injuries and gastrointestinal healing.
Choose TB-500 ifyou are recovering from muscle injuries, need systemic anti-inflammatory support, or want to improve overall flexibility and range of motion. TB-500's ability to travel systemically means it can find and repair damaged tissue throughout the body regardless of where it is injected.
Our recommendation: Stack both peptides for the most comprehensive healing protocol. BPC-157 and TB-500 work through complementary mechanisms, and their combined use is one of the most effective approaches to accelerated recovery available in regenerative medicine today. Our physicians will design a personalized protocol based on your specific injury, goals, and medical history.
Frequently Asked Questions
Is BPC-157 or TB-500 better for healing?
It depends on the type of injury. BPC-157 is superior for tendon, ligament, and gut healing due to its ability to upregulate growth factor receptors and promote angiogenesis (new blood vessel formation) at injury sites. TB-500 excels at muscle repair and systemic healing through its role in actin regulation and cellular migration. For comprehensive recovery, many practitioners stack both peptides together, as they work through complementary pathways and amplify each other's effects.
Can you stack BPC-157 and TB-500 together?
Yes, stacking BPC-157 and TB-500 is one of the most popular peptide protocols for accelerated healing. The combination is synergistic: BPC-157 enhances local tissue repair through growth factor upregulation while TB-500 promotes systemic healing through cell migration and actin organization. A typical stacking protocol involves BPC-157 at 250-500 mcg daily (subcutaneously near the injury site) combined with TB-500 at 2-5 mg twice weekly. This combination is particularly effective for musculoskeletal injuries, post-surgical recovery, and chronic tendon issues.
What is the correct dosing for BPC-157 vs TB-500?
BPC-157 is typically dosed at 250-500 mcg once or twice daily via subcutaneous injection near the injury site, or orally for gut-related conditions. Cycles usually run 4-8 weeks. TB-500 is dosed at 2-5 mg via subcutaneous or intramuscular injection, typically twice per week during a loading phase (2-4 weeks), then reduced to once weekly for maintenance. TB-500 cycles generally run 4-6 weeks. Both peptides should be administered under medical supervision to ensure proper dosing and monitoring.
Does BPC-157 work orally?
Yes, BPC-157 is unique among peptides because it maintains stability in gastric acid, allowing effective oral administration. This is notable because BPC-157 is derived from a protective compound found naturally in gastric juice. Oral BPC-157 is particularly effective for gastrointestinal conditions such as leaky gut, IBS, gastric ulcers, and inflammatory bowel issues. For musculoskeletal injuries, subcutaneous injection near the injury site is preferred as it delivers the peptide directly to the target tissue.
What are the side effects of BPC-157 and TB-500?
Both peptides have favorable safety profiles based on available research. BPC-157 side effects are rare and mild, potentially including slight nausea, dizziness, or injection site discomfort. TB-500 side effects are similarly minimal, with occasional injection site redness or temporary lethargy being the most commonly reported. Neither peptide has shown significant adverse effects in animal studies at therapeutic doses. However, both are still considered research peptides, and long-term human safety data is limited. Medical supervision is recommended.
How long does it take for BPC-157 and TB-500 to work?
BPC-157 often produces noticeable improvements within 1-2 weeks of consistent use, with some patients reporting reduced pain and inflammation within days. Full tendon or ligament healing benefits typically manifest over 4-8 weeks. TB-500 generally has a slightly longer onset, with initial effects noticed at 2-3 weeks and optimal results achieved after 4-6 weeks of consistent dosing. When stacked together, many patients report accelerated timelines compared to using either peptide alone.
Are BPC-157 and TB-500 legal?
BPC-157 and TB-500 are available as research peptides and can be legally prescribed by licensed physicians for therapeutic use in the United States. They are not FDA-approved drugs but are not classified as controlled substances. At Evolve Longevity, our physicians evaluate each patient to determine if peptide therapy is appropriate and provide medical oversight throughout the treatment protocol. We source all peptides from accredited, third-party tested compounding pharmacies to ensure purity and potency.